HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ropinirole for the treatment of tremor in early Parkinson's disease.

Abstract
The effect of Ropinirole on tremor in early Parkinson's disease (PD) was assessed. The results of three multicentre, randomized, double-blind trials comparing ropinirole monotherapy with levodopa, bromocriptine and placebo treatment were analysed retrospectively with respect to improvement of resting tremor and postural/action tremor as measured by items 20 and 21 of the motor section of the Unified Parkinson's Disease Rating Scale (UPDRS). Improvements in resting tremor were significantly better with ropinirole than placebo. There were no significant differences between the effect of ropinirole and those of levodopa (L-dopa) or bromocriptine on resting tremor. Postural/action tremor was mild in these early therapy studies, and there were no significant differences between treatment groups. These results suggest that ropinirole monotherapy is effective in treating resting tremor in early PD. On the other hand, response of postural/action tremor to dopaminergic treatment in early PD was not significantly better than to placebo at the dosages used in these trials.
AuthorsA Schrag, J Keens, J Warner, (Affiliation: Department of Clinical Neurology, Institute of Neurology, London, UK. a.schrag at ion.ucl.ac.uk)
JournalEuropean journal of neurology : the official journal of the European Federation of Neurological Societies (Eur J Neurol) Vol. 9 Issue 3 Pg. 253-7 (May 2002) ISSN: 1351-5101 [Print] England
PMID11985633 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiparkinson Agents
  • Indoles
  • Levodopa
  • ropinirole
  • Bromocriptine
Topics
  • Aged
  • Antiparkinson Agents (administration & dosage)
  • Bromocriptine (administration & dosage)
  • Double-Blind Method
  • Female
  • Humans
  • Indoles (administration & dosage)
  • Levodopa (administration & dosage)
  • Male
  • Middle Aged
  • Parkinson Disease (complications, drug therapy)
  • Treatment Outcome
  • Tremor (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD